
Evome Medical Technologies
(OTC) LNDZF
Evome Medical Technologies Financials at a Glance
Market Cap
$100
Revenue (TTM)
$48.34M
Net Income (TTM)
$23.53M
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
899.98 (High)
Dividend
$0.00
Beta (Volatility)
899.98 (High)
Price
$0.00
Volume
10,000
Open
$0.00
Price
$0.00
Volume
10,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
Dividend
$0.00
Beta (Volatility)
899.98 (High)
Price
$0.00
Volume
10,000
Open
$0.00
Previous Close
$0.00
Daily Range
$0.00 - $0.00
52-Week Range
$0.00 - $0.01
LNDZF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Evome Medical Technologies
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
205
CEO
Michael D. Seckler
Website
www.evomemedical.comHeadquarters
Shirley, CA 92014, US
LNDZF Financials
Key Financial Metrics (TTM)
Gross Margin
33%
Operating Margin
-24%
Net Income Margin
-24%
Return on Equity
0%
Return on Capital
-23%
Return on Assets
-10%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$100.00
Shares Outstanding
60.17M
Volume
10.00K
Avg. Volume
245.902
Financials (TTM)
Gross Profit
$22.53M
Operating Income
$5.52M
EBITDA
$10.42M
Operating Cash Flow
$918.91K
Capital Expenditure
$203.27K
Free Cash Flow
$1.12M
Cash & ST Invst.
$918.68K
Total Debt
$24.69M
Evome Medical Technologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$10.01M
-49.0%
Gross Profit
$3.56M
-51.0%
Gross Margin
35.58%
N/A
Market Cap
$100.00
N/A
Market Cap/Employee
$0.51
N/A
Employees
195
N/A
Net Income
$1.15M
-138.5%
EBITDA
$1.16M
-76.0%
Quarterly Fundamentals
Net Cash
$16.05M
+38.5%
Accounts Receivable
$6.74M
-44.7%
Inventory
$9.26M
-23.7%
Long Term Debt
$4.70M
-71.0%
Short Term Debt
$12.77M
-36.7%
Return on Assets
-10.24%
N/A
Return on Invested Capital
-22.79%
N/A
Free Cash Flow
$1.76M
+994.1%
Operating Cash Flow
$1.79M
+1787.9%